C12N 2720/12222
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2720/12222 (New viral proteins or individual genes, new structural or functional aspects of) appears on 22 US grants and 36 published applications in this corpus.
Search patents in C12N- Granted patents
- 22
- Published applications
- 36
- Assignees
- 19
- Inventors
- 49
- Latest grant
- 13 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 1 | 2 |
| 2011 | 0 | 2 |
| 2012 | 1 | 2 |
| 2013 | 0 | 3 |
| 2014 | 2 | 2 |
| 2015 | 0 | 0 |
| 2016 | 4 | 1 |
| 2017 | 0 | 2 |
| 2018 | 3 | 4 |
| 2019 | 1 | 1 |
| 2020 | 2 | 3 |
| 2021 | 2 | 2 |
| 2022 | 1 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 4 |
| 2025 | 1 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oncolytic reovirus13 May 2025US 12,295,977 B2
- Fusogenic lipid nanoparticles for target cell-specific production of a therapeutic protein14 Mar 2023US 11,603,543 B2Oisin Biotechnologies, Inc.
- Reoviruses having modified sequences15 Feb 2022US 11,246,930 B2Oncolytics Biotech Inc.
- Protein muNS that can form inclusions in the endoplasmic reticulum, methods for the use thereof and uses of same16 Nov 2021US 11,174,485 B2Universid Ade De Santiago De Compostela
- Avian reovirus vaccines17 Aug 2021US 11,090,377 B2University of Georgia Research Foundation, Inc.
- Muns fusion protein capable of forming microspheres and uses thereof27 Aug 2026US 2026/0248905 A1Universidade De Santiago De Compostela
- Fusogenic lipid nanoparticles and methods for the manufacture and use thereof for the target cell-specific production of a therapeutic protein and for the treatment of a disease13 Nov 2025US 2025/0346925 A1Oisin Biotechnologies, Inc.
- Compositions and methods for expressing antigens on cell membrane20 Feb 2025US 2025/0057937 A1Zoetis Services LLC
- Proteolipid vesicles formulated with fusion associated small transmembrane proteins14 Nov 2024US 2024/0374520 A1Entos Pharmaceuticals Inc.
- Compositions and methods for liver-specific expression of follistatin14 Nov 2024US 2024/0374760 A1Oisin Biotechnologies, Inc.
Most cited
By later US patents
- Rotavirus nucleocapsid protein VP6 as a carrier in vaccine compositions50US 5,071,651 AUniversity of Saskatchewan · 1991
- Rotavirus nucleocapsid protein VP6 in vaccine compositions42US 5,374,426 AUniversity of Saskatchewan · 1994
- Viral purification methods41US 7,223,585 B2Oncolytics Biotech Inc. · 2007
- Viral purification methods34US 8,685,734 B2Oncolytics Biotech Inc. · 2014
- Reoviruses having modified sequences11US 7,803,385 B2Oncolytics Biotech Inc. · 2010